{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:07:19Z","timestamp":1788973639745,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777372"],"award-info":[{"award-number":["777372"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.slasd.2026.100333","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:03:22Z","timestamp":1787756602000},"page":"100333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of diversified HTS cell-based assays for solute carrier drug discovery"],"prefix":"10.1016","volume":"43","author":[{"given":"Francesca","family":"Sassone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Batoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tremolada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-3406","authenticated-orcid":false,"given":"Fernanda","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Scarabottolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.slasd.2026.100333_bib0001","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mam.2012.12.009","article-title":"The ABCs of membrane transporters in health and disease (SLC series): introduction","volume":"34","author":"Hediger","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10.1016\/j.slasd.2026.100333_bib0002","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/molbev\/msq350","article-title":"The solute carrier families have a remarkably long evolutionary history with the majority of the human families present before divergence of bilaterian species","volume":"28","author":"Hoglund","year":"2011","journal-title":"Mol Biol Evol"},{"issue":"10","key":"10.1016\/j.slasd.2026.100333_bib0003","first-page":"865","article-title":"[New data on the functional diagnosis of hepatitis in children]","volume":"21","author":"Str\u00f6der","year":"1966","journal-title":"Cesk Pediatr"},{"key":"10.1016\/j.slasd.2026.100333_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722889","article-title":"An overview of cell-based assay platforms for the solute carrier family of transporters","volume":"12","author":"Dvorak","year":"2021","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.slasd.2026.100333_bib0005","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.tips.2019.08.006","article-title":"Advances and challenges in rational drug design for SLCs","volume":"40","author":"Garibsingh","year":"2019","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.slasd.2026.100333_bib0006","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.chembiol.2023.06.029","article-title":"Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors","volume":"30","author":"Dvorak","year":"2023","journal-title":"Cell Chem Biol"},{"issue":"4","key":"10.1016\/j.slasd.2026.100333_bib0007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2472555218755629","article-title":"Amino acid transporters as disease modifiers and drug targets","volume":"23","author":"Br\u00f6er","year":"2018","journal-title":"SLAS Discov"},{"issue":"7","key":"10.1016\/j.slasd.2026.100333_bib0008","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ng.3313","article-title":"A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome","volume":"47","author":"Alakbarzade","year":"2015","journal-title":"Nat Genet"},{"issue":"7501","key":"10.1016\/j.slasd.2026.100333_bib0009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood\u2013brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.slasd.2026.100333_bib0010","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1074\/jbc.M116.721340","article-title":"Mfsd2a is a transporter for the essential \u03c9-3 fatty acid docosahexaenoic acid (DHA) in eye and is important for photoreceptor cell development","volume":"291","author":"Wong","year":"2016","journal-title":"J Biol Chem"},{"issue":"7501","key":"10.1016\/j.slasd.2026.100333_bib0011","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.slasd.2026.100333_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050629","article-title":"Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism","volume":"7","author":"Berger","year":"2012","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.slasd.2026.100333_bib0013","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41431-020-0669-x","article-title":"Biallelic MFSD2A variants associated with congenital microcephaly, developmental delay, and recognizable neuroimaging features","volume":"28","author":"Scala","year":"2020","journal-title":"Eur J Hum Genet EJHG"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/ijms21010070","article-title":"Decreased blood level of MFSD2a as a potential biomarker of Alzheimer\u2019s disease","volume":"21","author":"S\u00e1nchez-Campillo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7872","key":"10.1016\/j.slasd.2026.100333_bib0015","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03782-y","article-title":"Structure and mechanism of blood\u2013brain-barrier lipid transporter MFSD2A","volume":"596","author":"Wood","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.slasd.2026.100333_bib0016","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41594-022-00786-8","article-title":"Structural insights into the lysophospholipid brain uptake mechanism and its inhibition by syncytin-2","volume":"29","author":"Martinez-Molledo","year":"2022","journal-title":"Nat Struct Mol Biol"},{"issue":"7866","key":"10.1016\/j.slasd.2026.100333_bib0017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-021-03650-9","article-title":"Structural basis of omega-3 fatty acid transport across the blood\u2013brain barrier","volume":"595","author":"Cater","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0018","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-023-39088-y","article-title":"Substrate binding-induced conformational transitions in the omega-3 fatty acid transporter MFSD2A","volume":"14","author":"Bergman","year":"2023","journal-title":"Nat Commun"},{"issue":"45","key":"10.1016\/j.slasd.2026.100333_bib0019","doi-asserted-by":"crossref","first-page":"17532","DOI":"10.1073\/pnas.0807413105","article-title":"A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2","volume":"105","author":"Esnault","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"22","key":"10.1016\/j.slasd.2026.100333_bib0020","doi-asserted-by":"crossref","first-page":"13013","DOI":"10.1073\/pnas.2132646100","article-title":"Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution","volume":"100","author":"Blaise","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.slasd.2026.100333_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111208","article-title":"Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and in anaphylactic shock","volume":"40","author":"Le","year":"2022","journal-title":"Cell Rep"},{"issue":"17","key":"10.1016\/j.slasd.2026.100333_bib0022","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood\u2013brain barrier by targeting endothelial sphingosine 1\u2013phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"10.1016\/j.slasd.2026.100333_bib0023","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.cell.2023.04.028","article-title":"Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.slasd.2026.100333_bib0024","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.012941","article-title":"Erythrocytes efficiently utilize exogenous sphingosines for S1P synthesis and export via Mfsd2b","volume":"296","author":"Nguyen","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0025","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/s41598-018-23300-x","article-title":"MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells","volume":"8","author":"Kobayashi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.slasd.2026.100333_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108483","article-title":"An erythrocyte-centric view on the MFSD2B sphingosine-1-phosphate transporter","volume":"249","author":"Ghaderi","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0027","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1086\/422102","article-title":"High prevalence of SLC6A8 deficiency in X-linked mental retardation","volume":"75","author":"Rosenberg","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.slasd.2026.100333_bib0028","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.immuni.2019.06.007","article-title":"Slc6a8-Mediated creatine uptake and accumulation reprogram macrophage polarization via regulating cytokine responses","volume":"51","author":"Ji","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.slasd.2026.100333_bib0029","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/164_2017_71","article-title":"SLC6 transporter folding diseases and pharmacochaperoning","volume":"245","author":"Freissmuth","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.slasd.2026.100333_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2020.588954","article-title":"The creatine transporter unfolded: a knotty premise in the cerebral Creatine deficiency syndrome","volume":"12","author":"Farr","year":"2020","journal-title":"Front Synaptic Neurosci"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0031","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2021.12.005","article-title":"Current and potential new treatment strategies for creatine deficiency syndromes","volume":"135","author":"Fernandes-Pires","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.slasd.2026.100333_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2024.08.644","volume":"35","author":"Hendifar","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.slasd.2026.100333_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.898508","article-title":"The less well-known little brothers: the SLC9B\/NHA sodium proton exchanger subfamily-structure, function, regulation and potential drug-target approaches","volume":"13","author":"Anderegg","year":"2022","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.slasd.2026.100333_bib0034","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.3390\/ijms26094221","article-title":"Structure and inhibition of the human Na+\/H+ exchanger SLC9B2","volume":"26","author":"Jung","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.slasd.2026.100333_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bone.2010.04.605","article-title":"Sodium\/hydrogen exchanger NHA2 in osteoclasts: subcellular localization and role in vitro and in vivo","volume":"47","author":"Hofstetter","year":"2010","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.slasd.2026.100333_bib0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.mnh.0000447013.36475.96","article-title":"Role of Na\/H exchange in insulin secretion by islet cells","volume":"23","author":"Deisl","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"47","key":"10.1016\/j.slasd.2026.100333_bib0037","doi-asserted-by":"crossref","first-page":"18677","DOI":"10.1073\/pnas.0707120104","article-title":"A human Na+\/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension","volume":"104","author":"Xiang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.slasd.2026.100333_bib0038","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41594-022-00738-2","article-title":"Structure, mechanism and lipid-mediated remodeling of the mammalian Na+\/H+ exchanger NHA2","volume":"29","author":"Matsuoka","year":"2022","journal-title":"Nat Struct Mol Biol"},{"issue":"43","key":"10.1016\/j.slasd.2026.100333_bib0039","doi-asserted-by":"crossref","first-page":"36239","DOI":"10.1074\/jbc.M112.403550","article-title":"Unconventional chemiosmotic coupling of NHA2, a mammalian Na+\/H+ antiporter, to a plasma membrane H+ gradient","volume":"287","author":"Kondapalli","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/function\/zqaa028","article-title":"NKCC1: newly found as a human disease-causing ion transporter","volume":"2","author":"Koumangoye","year":"2020","journal-title":"Function"},{"issue":"2","key":"10.1016\/j.slasd.2026.100333_bib0041","doi-asserted-by":"crossref","first-page":"C385","DOI":"10.1152\/ajpcell.00238.2023","article-title":"NKCC1 in human diseases: is the SLC12A2 gene haploinsufficient?","volume":"325","author":"Delpire","year":"2023","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"S1","key":"10.1016\/j.slasd.2026.100333_bib0042","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1152\/physiol.2025.40.S1.1439","article-title":"Abnormal exocrine pancreas histology in NKCC1-deficient mice","volume":"40","author":"Koumangoye","year":"2025","journal-title":"Physiology"},{"issue":"4","key":"10.1016\/j.slasd.2026.100333_bib0043","doi-asserted-by":"crossref","first-page":"C1251","DOI":"10.1152\/ajpcell.00334.2022","article-title":"Loss of NKCC1 function increases epithelial tight junction permeability by upregulating claudin-2 expression","volume":"323","author":"Koumangoye","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.slasd.2026.100333_bib0044","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tips.2021.09.005","article-title":"Pharmacological tools to target NKCC1 in brain disorders","volume":"42","author":"Savardi","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.slasd.2026.100333_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108910","article-title":"CNS pharmacology of NKCC1 inhibitors","volume":"205","author":"L\u00f6scher","year":"2022","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0046","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10534-022-00474-6","article-title":"Functional characterization of SLC39 family members ZIP5 and ZIP10 in overexpressing HEK293 cells reveals selective copper transport activity","volume":"36","author":"Polesel","year":"2023","journal-title":"BioMetals"},{"issue":"11","key":"10.1016\/j.slasd.2026.100333_bib0047","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.bcp.2004.02.013","article-title":"Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay","volume":"67","author":"Jensen","year":"2004","journal-title":"Biochem Pharmacol"},{"issue":"29","key":"10.1016\/j.slasd.2026.100333_bib0048","doi-asserted-by":"crossref","first-page":"11756","DOI":"10.1073\/pnas.1018098108","article-title":"A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin","volume":"108","author":"Reiling","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"20","key":"10.1016\/j.slasd.2026.100333_bib0049","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.3390\/ijms21207465","article-title":"Coelenterazine-dependent luciferases as a powerful analytical tool for research and biomedical applications","volume":"21","author":"Krasitskaya","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20111929","article-title":"Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1","volume":"444","author":"Schnute","year":"2012","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.slasd.2026.100333_bib0051","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/abbi.1998.0959","article-title":"Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes","volume":"361","author":"Dai","year":"1999","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10.1016\/j.slasd.2026.100333_bib0052","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","article-title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities","volume":"48","author":"Schlessinger","year":"2023","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.slasd.2026.100333_bib0053","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"C\u00e9sar-Razquin","year":"2015","journal-title":"Cell"},{"issue":"5930","key":"10.1016\/j.slasd.2026.100333_bib0054","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg Effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.slasd.2026.100333_bib0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.slasd.2026.100333_bib0056","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-throughput screening: today\u2019s biochemical and cell-based approaches","volume":"25","author":"Blay","year":"2020","journal-title":"Drug Discov Today"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555226000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:08:09Z","timestamp":1788970089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555226000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S2472555226000390"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100333","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of diversified HTS cell-based assays for solute carrier drug discovery","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2026.100333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100333"}}